Jefferies Financial Group’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.72M | Sell |
8,342
-7,005
| -46% | -$2.28M | 0.02% | 318 |
|
|
2025
Q1 | $4.14M | Buy |
+15,347
| New | +$4.14M | 0.04% | 259 |
|
|
2024
Q4 | – | Sell |
-47,193
| Closed | -$13M | – | 1240 |
|
|
2024
Q3 | $13M | Buy |
47,193
+44,893
| +1,952% | +$12.3M | 0.09% | 80 |
|
|
2024
Q2 | $559K | Buy |
2,300
+458
| +25% | +$111K | 0.01% | 716 |
|
|
2024
Q1 | $275K | Buy |
1,842
+1,696
| +1,162% | +$253K | ﹤0.01% | 945 |
|
|
2023
Q4 | $27.9K | Sell |
146
-4,632
| -97% | -$887K | ﹤0.01% | 1182 |
|
|
2023
Q3 | $846K | Sell |
4,778
-5,129
| -52% | -$908K | 0.01% | 559 |
|
|
2023
Q2 | $1.88M | Buy |
9,907
+5,367
| +118% | +$1.02M | 0.02% | 403 |
|
|
2023
Q1 | $909K | Sell |
4,540
-6,171
| -58% | -$1.24M | 0.01% | 578 |
|
|
2022
Q4 | $2.55M | Buy |
+10,711
| New | +$2.55M | 0.02% | 310 |
|